Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acid-producing oral bacteria are a group of microorganisms in the oral cavity that metabolize dietary carbohydrates—especially sugars like sucrose, glucose, and fructose—into organic acids such as lactic acid. These acids lower the local pH in dental plaque and can demineralize tooth enamel, leading to dental caries (cavities). Key species include Streptococcus mutans, Lactobacillus spp., Veillonella spp., and Bifidobacterium spp. They adhere to tooth surfaces within biofilms known as dental plaque and metabolize dietary sugars anaerobically via glycolysis, producing organic acids (primarily lactic acid). The resulting acidic environment (pH < 5.0) leads to demineralization of enamel and dentin, promoting cavity formation. Controlling populations or activity levels of these bacteria through diet modification, improved oral hygiene, or use of antimicrobial agents is key for preventing cavities.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acid-producing oral bacteria (None).